Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-11-02
2000-12-12
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
4241951, 514249, 514261, 514732, 514738, 546 93, 546 97, A01N 4342, A01N 6500, C07D22106
Patent
active
061599867
ABSTRACT:
Therapies and compounds for the inhibition of memory loss. In one embodiment, a combination of Huperzine A and hypericin is employed.
REFERENCES:
patent: 4898891 (1990-02-01), Lavie et al.
patent: 5049589 (1991-09-01), Lavie et al.
patent: 5106979 (1992-04-01), Kozikowski et al.
patent: 5506271 (1996-04-01), Meruelo et al.
patent: 5514714 (1996-05-01), Meruelo et al.
patent: 5820867 (1998-10-01), Bewicke
patent: 5877173 (1999-03-01), Olney et al.
patent: 5889033 (1999-03-01), Kaminski
patent: 5929084 (1999-07-01), Zhu et al.
patent: 5985282 (1999-11-01), Haveson
patent: 5989919 (1999-03-01), Olney et al.
patent: 6037327 (2000-03-01), Castillo et al.
Computer Abstract EPAB Roumeliotis DE3935772 "PRPN of St Jhohn's Wort Extract Enriched With Hypericin . . .", Apr. 1991.
LandOfFree
Compounds and therapy for resisting memory loss in humans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and therapy for resisting memory loss in humans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and therapy for resisting memory loss in humans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-217982